Government Pushes Non‑Animal Research Models
The Ministry of Science & Technology has highlighted the need for more human‑relevant, non‑animal models in drug discovery. Limited validated models slow research, raise costs and increase dependence on animal experiments. To address this, laboratories under ICMR, CSIR and DBT are strengthening advanced in‑vitro, 3‑D tissue, organoid and computational approaches.
Key Developments
- ICMR has funded 109 projects on non‑animal testing (organ‑on‑chip, 3‑D tissue models, in‑silico) across 71 institutes.
- CSIR reports that eight of its laboratories now have capabilities in NAMs, including organ‑on‑chip and organoid platforms.
- DBT autonomous institutes like BRIC‑inStem (Bengaluru) and THSTI (Faridabad) have dedicated infrastructure for cell culture, 2D/3D co‑cultures, micro‑physiological systems and high‑throughput screening.
- The BIRAC supports the Centre for Predictive Human Model Systems at CCMB (Hyderabad), which maintains a public database of researchers working on organoids, organs‑on‑chip and 3‑D tissues.
- Specific projects include a lung‑on‑chip for monoclonal antibody testing and a kidney‑on‑chip device mimicking human renal function.
Important Facts
The push for non‑animal methods is still complementary to animal models, especially for complex biology. However, the government aims to reduce reliance by building capacity, validating models, and encouraging industry‑academia collaboration. Funding calls such as “Establishment of Preclinical Models for Drug Discovery” have been issued to develop robust organoid and organ‑on‑chip platforms.
Exam Relevance
Understanding these initiatives is vital for GS III (Science & Technology) and GS II (Polity) as they illustrate:
- Policy formulation by a central ministry and its impact on research ecosystems.
- Inter‑ministerial coordination among ICMR, CSIR and DBT.
- Emergence of organoids and NAMs as cutting‑edge tools in biomedical research.
- Ethical considerations (GS IV) regarding animal welfare and the shift toward humane research methods.
Way Forward
To fully replace animal models, the government should:
- Accelerate validation of non‑animal platforms through standardized protocols.
- Increase funding for interdisciplinary projects that integrate biology, engineering and data science.
- Promote public‑private partnerships to scale up manufacturing of organ‑on‑chip devices.
- Strengthen the national database (CCMB) for better collaboration and knowledge sharing.
- Incorporate non‑animal methods into regulatory guidelines for drug approval.